EYEPOINT PHARMAECUTIALS, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 3rd, 2021 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments • New York
FIRST AMENDMENT TO SHARE PURCHASE AGREEMENTShare Purchase Agreement • February 3rd, 2021 • EyePoint Pharmaceuticals, Inc. • Laboratory analytical instruments • Delaware
THIS FIRST AMENDMENT TO SHARE PURCHASE AGREEMENT (this “First Amendment”) is entered into and made effective as of February 1, 2021 (the “Effective Date”), by and between Ocumension Therapeutics, incorporated in the Cayman Islands with limited liability (“Investor”), and EyePoint Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Investor and the Company are sometimes individually referred to herein as a “Party” or collectively referred to herein as the “Parties.”
